We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Enzo Biochem Inc (ENZ) Com Stk USD0.01

Sell:$1.10 Buy:$1.13 Change: $0.02 (1.77%)
Market closed |  Prices as at close on 13 September 2024 | Switch to live prices |
Sell:$1.10
Buy:$1.13
Change: $0.02 (1.77%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 13 September 2024 | Switch to live prices |
Sell:$1.10
Buy:$1.13
Change: $0.02 (1.77%)
Market closed |  Prices as at close on 13 September 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The Company's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. It has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.

Contact details

Address:
60 EXECUTIVE BLVD
FARMINGDALE
11735
United States
Telephone:
+1 (516) 7555500
Website:
https://www.enzo.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ENZ
ISIN:
US2941001024
Market cap:
$57.12 million
Shares in issue:
51.46 million
Sector:
Health Care Services
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Steven Pully
    Chairman of the Board
  • Kara Cannon
    Chief Executive Officer, Chief Operating Officer
  • Patricia Eckert
    Chief Financial Officer
  • Matthew Kupferberg
    General Counsel, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.